Cephamycin Resistance in Clinical Isolates and Laboratory-derived Strains of Escherichia coli, Nova Scotia, Canada
2003

Cephamycin Resistance in E. coli

Sample size: 28 publication 10 minutes Evidence: moderate

Author Information

Author(s): Clarke Brian, Hiltz Margot, Musgrave Heather, Forward Kevin R.

Primary Institution: Dalhousie University and the Queen Elizabeth II Health Sciences Centre

Hypothesis

What are the mechanisms behind cephamycin resistance in Escherichia coli?

Conclusion

The study found that promoter and attenuator mutations are common causes of cephamycin resistance in E. coli strains.

Supporting Evidence

  • E. coli strains with reduced susceptibility to cefoxitin were also resistant to other antibiotics.
  • Promoter mutations were found to be a common cause of increased AmpC β-lactamase production.
  • Eight out of ten laboratory strains developed cefoxitin resistance after serial passage.

Takeaway

Some E. coli can become resistant to a type of antibiotic called cephamycin, and this happens because of changes in their genes.

Methodology

The study analyzed 18 clinical isolates and 10 laboratory-derived strains of E. coli for mutations and resistance mechanisms.

Limitations

Limited information on patient movement within the healthcare system made it difficult to define a common source for the strains.

Participant Demographics

Strains collected from inpatients and community patients in Nova Scotia, Canada.

Digital Object Identifier (DOI)

10.3201/eid0910.030093

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication